Epidemiology and burden of alopecia areata: A systematic review

Clinical, Cosmetic and Investigational Dermatology

Volumn 8, Issue , 2015, Pages 397-403

  Villasante Fricke, Alexandra C ^a   Miteva, Mariya ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Burden of disease; Hair; Hair loss; Incidence; Prevalence

Indexed keywords

AGE DISTRIBUTION; ALOPECIA AREATA; ANXIETY; ATOPY; COMORBIDITY; DEPRESSION; FAMILY HISTORY; HUMAN; ONSET AGE; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEX RATIO; SYSTEMATIC REVIEW; THYROID DISEASE; VITILIGO;

EID: 84938236167     PISSN: None     EISSN: 11787015     Source Type: Journal    
DOI: 10.2147/CCID.S53985     Document Type: Review

References (55)

1. Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S13-S15.
2. MacLean KJ, Tidman MJ. Alopecia areata: more than skin deep. Practitioner. 2013;257(1764):29-32,3.
3. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81-89.
4. Christoph T, Muller-Rover S, Audring H, et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol. 2000;142(5):862-873.
5. Cetin ED, Savk E, Uslu M, Eskin M, Karul A. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol. 2009;31(1):53-60.
6. Xing L, Dai Z, Jabbari A, et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014; 20(9):1043-1049.
7. Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466(7302):113-117.
8. Shapiro J. Current treatment of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S42-S44.
9. Karimkhani C, Boyers LN, Prescott L, et al. Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol. 2014;150(9):945-951.
10. Mirzoyev SA, Schrum AG, Davis MD, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol. 2014;134(4):1141-1142.
11. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70(7):628-633.
12. Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol. 1992;128(5):702.
13. Guzmán-Sánchez DA, Villanueva-Quintero GD, Alfaro Alfaro N, McMichael A. A clinical study of alopecia areata in Mexico. Int J Dermatol. 2007;46(12):1308-1310.
14. Price VH. Alopecia areata: clinical aspects. J Invest Dermatol. 1991; 96(5):68S.
15. Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol. 1996;35(1):22-27.
16. Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore - a study of 219 Asians. Int J Dermatol. 2002;41(11):748-753.
17. McMichael AJ, Pearce DJ, Wasserman D, et al. Alopecia in the United States: outpatient utilization and common prescribing patterns. J Am Acad Dermatol. 2007;57(2 Suppl):S49-S51.
18. Furue M, Yamazaki S, Jimbow K, et al. Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study. J Dermatol. 2011;38(4):310-320.
19. Tan E, Tay YK, Giam YC. A clinical study of childhood alopecia areata in Singapore. Pediatr Dermatol. 2002;19(4):298-301.
20. Yang S, Yang J, Liu JB, et al. The genetic epidemiology of alopecia areata in China. Br J Dermatol. 2004;151(1):16-23.
21. Rocha J, Ventura F, Vieira AP, Pinheiro AR, Fernandes S, Brito C. [Alopecia areata: a retrospective study of the paediatric dermatology department (2000-2008)]. Acta Med Port. 2011;24(2):207-214. Portuguese.
22. Nanda A, Al-Fouzan AS, Al-Hasawi F. Alopecia areata in children: a clinical profile. Pediatr Dermatol. 2002;19(6):482-485.
23. Xiao FL, Yang S, Liu JB, et al. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol. 2006;23(1): 13-18.
24. Lundin M, Chawa S, Sachdev A, Bhanusali D, Seiffert-Sinha K, Sinha AA. Gender differences in alopecia areata. J Drugs Dermatol. 2014;13(4):409-413.
25. Barahmani N, Schabath MB, Duvic M; National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581-591.
26. Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol. 1992; 31(3):186-189.
27. Blaumeiser B, van der Goot I, Fimmers R, et al. Familial aggregation of alopecia areata. J Am Acad Dermatol. 2006;54(4):627-632.
28. Kyriakis KP, Paltatzidou K, Kosma E, Sofouri E, Tadros A, Rachioti E. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol. 2009;23(5):572-573.
29. Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A. Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol. 2005;5:11.
30. Kavak A, Yeşildal N, Parlak AH, et al. Alopecia areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol. 2008;22(8):977-981.
31. Jain S, Marfatia YS. Alopecia areata - pattern in industrial city of Baroda. Indian J Dermatol Venereol Leprol. 2003;69(2):81-82.
32. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20(9):1055-1060.
33. Muller SA, Winkelmann RK. Alopecia Areata. An evaluation of 736 patients. Arch Dermatol. 1963;88:290-297.
34. Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5): 949-956.
35. Kakourou T, Karachristou K, Chrousos G. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J Eur Acad Dermatol Venereol. 2007;21(3): 356-359.
36. Tak WJ, Chung YS, Ro BI. [A clinical study on alopecia areata (1996-2000) (TGF-VI)]. Korean J Dermatol. 2002;40(7):791-800. Korean.
37. Search GBD Data [webpage on the Internet]. Seattle, WA: Institute for Health Metrics and Evaluation; 2014 [cited February 13, 2015]. Available from: http://www.healthdata.org/search-gbd-data?s=Alopecia%20areata. Accessed February 13, 2015.
38. Shi Q, Duvic M, Osei JS, et al. Health-Related Quality of Life (HRQoL) in alopecia areata patients - a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc. 2013;16(1):S49-S50.
39. Colón EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry. 1991;32(3):245-251.
40. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol. 2003;42(6):434-437.
41. Sellami R, Masmoudi J, Ouali U, et al. The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study. Indian J Dermatol. 2014;59(4):421.
42. Chu SY, Chen YJ, Tseng WC, et al. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol. 2012;166(3):525-531.
43. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846-850.
44. Sinclair RD. Alopecia areata and suicide of children. Med J Aust. 2014;200(3):145.
45. Tosti A. Practice gaps. Alopecia areata and comorbid conditions. JAMA Dermatol. 2013;149(7):794.
46. Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149(7):789-794.
47. Nnoruka EN, Obiagboso I, Maduechesi C. Hair loss in children in South-East Nigeria: common and uncommon cases. Int J Dermatol. 2007;46 Suppl 1:18-22.
48. Baars MP, Greebe RJ, Pop VJ. High prevalence of thyroid peroxidase antibodies in patients with alopecia areata. J Eur Acad Dermatol Venereol. 2013;27(1):e137-e139.
49. Karadag AS, Ertugrul DT, Bilgili SG, Takci Z, Tutal E, Yilmaz H. Insulin resistance is increased in alopecia areata patients. Cutan Ocul Toxicol. 2013;32(2):102-106.
50. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117(8):2019-2027.
51. Redler S, Angisch M, Heilmann S, et al. Immunochip-based analysis: high-density genotyping of immune-related Loci sheds further light on the autoimmune genetic architecture of alopecia areata. J Invest Dermatol. 2015;135(3):919-921.
52. Conteduca G, Rossi A, Megiorni F, et al. Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with alopecia areata. Clin Exp Med. 2014;14(1):91-97.
53. Megiorni F, Mora B, Maxia C, Gerardi M, Pizzuti A, Rossi A. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in alopecia areata: a case-control association study in the Italian population. Arch Dermatol Res. 2013;305(7):665-670.
54. Betz RC, Petukhova L, Ripke S, et al. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015;6:5966.
55. Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol. 1994;33(12):849-850.